Related by context. All words. (Click for frequent words.) 82 mediate antibody 71 attach auristatin 70 RON Notch 70 based pretargeting methods 70 B lymphocyte stimulator 70 pathophysiological effects 69 MCSP respectively 69 humanized monoclonal antibodies 69 Factor Receptor 69 vitro ERBITUX 69 HuCAL PLATINUM ® CysDisplay 69 c MET 68 5 HT2A serotonin 68 IAP inhibitor 68 androgen receptor AR 68 selective inhibition 68 agonistic human 68 ADCC enhanced 67 CEA CD# Her2 67 effector functions 67 Alfacell proprietary ribonuclease 67 anionic backbone 67 herpes simplex viruses 67 BRAF kinase 67 serine threonine 67 thymidylate synthase TS 67 tyrosine kinase receptor 66 product candidate Lpathomab 66 Locked Nucleic Acid 66 CysDisplay R 66 CYP#A# CYP#D# 66 Vaccine Adjuvant 66 protein tyrosine phosphatase 1B 66 effector function 66 replicon 66 Tumor necrosis factor 66 UltiMAb TM 66 MSCRAMM ® 66 proprietary BiTE ® 66 retinoic acid receptor 66 IgG1 66 serine proteases 66 Y2 receptor 66 AAG geldanamycin analog 66 poly ADP ribose polymerase 66 PECAM 66 novel VDA molecule 65 TRIOLEX HE# APOPTONE HE# 65 histone deacetylase HDAC 65 endosomal release 65 including HGF ErbB3 65 anti botulism antibody 65 specific lectin receptors 65 Potelligent TM Technology 65 Cytotoxic T 65 certain protein tyrosine 65 Hypoxia Inducible Factor 65 sunitinib Sutent ® 65 anti CD3 65 kidney urologic 65 CD# CEA 65 MEK ERK 65 MT#/MEDI-# 65 Crucell genetically engineered 65 myelofibrosis polycythemia vera 65 lysophosphatidic acid LPA 65 drug conjugates ADCs 65 innate immune responses 65 HuCAL GOLD R 65 related apoptosis inducing 65 apoptosis proteins 65 hypoxia inducible factor 65 ribonucleotide reductase clinically validated 65 cytotoxic T 65 recombinant subunit vaccine 65 soluble tumor necrosis 65 deacetylase 65 M2 subunit 65 Th1 type 65 Protein Kinase C 65 phosphorylates 64 RAS RAF MEK 64 A3 adenosine receptor 64 kinase PI3K Akt pathway 64 orally administered inhibitor 64 methyl D aspartate 64 XL# anticancer compounds 64 Epothilones 64 monocytes macrophages 64 NS5b 64 peptidic compound 64 factor TNF receptor 64 myeloid derived 64 telomerase reverse transcriptase 64 ENMD # 64 HIF 1alpha 64 c MYC 64 accumulate preferentially 64 TRAIL induced apoptosis 64 glucocerebroside primarily 64 XmAb TM 64 Cathepsin B 64 erlotinib Tarceva ® 64 polysaccharide polymer 64 SGLT2 64 receptor inhibiting monoclonal 64 cytolytic 64 FGFR 64 PDGFR B 64 Staphylococcus aureus Immune Globulin 64 protease activated 64 POTELLIGENT R 64 cyclin dependent kinases CDKs 64 peptide antigens 64 small molecule defensin 64 JAK#/JAK# 64 sodium glucose cotransporter 64 tests miRview TM 64 alpha folate receptor 64 candidates Azedra TM 64 potently inhibited 64 CYT# potent vascular disrupting 64 reversibly inhibits 64 triggers apoptosis programmed 64 PATENT FOR 64 immune stimulatory 64 RANK Ligand 64 ERK1 2 64 humoral immunity 64 oncolytic virus therapies 64 GlycoPEGylated hemostasis compounds 64 T#I mutant 64 fatty acid biosynthesis 64 Ribavirin causes 63 PDGF receptor 63 plasmacytoid dendritic cells 63 live Lm vaccines 63 super oxide dismutase 63 platform HDL Mimetic 63 oral prodrug 63 Platelet Derived Growth 63 CRF1 receptor 63 PTP 1B 63 POTELLIGENT ® 63 CD4 monoclonal antibody 63 TNF alpha selectively neutralizing 63 C5aR 63 Vidofludimus 63 5 HT6 63 mTOR kinase 63 IL #p# 63 induce apoptosis 63 HuCAL derived fully 63 includes S. anginosus 63 p# alpha [001] 63 selective kinase inhibitor 63 TRAIL R2 63 anti gastrin monoclonal 63 monocyte chemotactic protein 63 gastro intestinal inflammation 63 interleukin IL -# 63 proprietary synthetic peptides 63 HCV RNA polymerase 63 cyclic AMP cAMP 63 cytoprotective 63 liver colon rectal 63 HUMIRA resembles 63 bioactive lipids 63 Fibroblast Growth Factor Receptor 63 DNA methyltransferase inhibitors 63 targeted anticancer biopharmaceuticals 63 Intravenous Human 63 neuronal nitric oxide synthase 63 D aspartate NMDA receptor 63 prodrugs 63 p# MAPK 63 factor HGF 63 antiangiogenesis therapies 63 MAP kinases 63 intercellular adhesion molecule 63 immunotoxins 63 HuLuc# 63 Epidermal Growth Factor Receptor 63 delta isoform 63 PI3 kinase 63 killer NK 63 dihydrofolate reductase 63 selective orally bioavailable 63 potently inhibit 63 POTELLIGENT ® Technology 63 HER1 63 acting fibrinolytic 63 apoptotic pathway 63 5 HT2A receptor 63 RAS MAPK pathway 63 attracts EPCs circulating 63 Crofelemer budesonide foam 63 Addex Pharmaceuticals www.addexpharma.com discoverMunsif Khan spokesman 63 Preclinical studies suggest 63 Eg5 63 FasL 63 active AKT inhibitor 63 Akt pathway associated 63 Hepatocytes 63 oncoproteins 63 PROSTASCINT R 63 immunostimulatory 63 oncogenic signaling 63 HGS ETR1 mapatumumab 63 tensin homolog 63 Xencor XmAb 63 JAK1 63 NMDA N 63 ALN TTR 63 selectively inhibit replication 63 chemokine receptors 63 Ras MAPK pathway 62 JAK2 enzyme 62 genus Plasmodium 62 PI3K/mTOR 62 downregulating 62 prostate secretory 62 dasatinib Sprycel ® 62 Interferon gamma 62 S. intermedius 62 chemically modified siRNA 62 Personalized Immunotherapy 62 XOMA 3AB 62 targeting CD# 62 PDE4 62 mitotic kinesin 62 inverse agonist 62 TLR9 62 TNFalpha 62 somatostatin 62 granulocyte macrophage colony stimulating 62 ATRA IV 62 monoclonal antibody IgG1 Mab 62 R Saizen R 62 Ad5FGF 4 62 mTOR mammalian target 62 transthyretin TTR 62 oral ferric iron 62 Selective Inhibitor 62 inhibits plasma kallikrein 62 macrophage colony stimulating 62 Eg5 kinesin motor 62 anti inflammatory cytokine 62 FLT3 62 bone marrow lymph nodes 62 Dendritic cells DCs 62 antiviral cytokines 62 Fc receptor 62 HGS ETR2 62 N chlorinated antimicrobial 62 Factor VEGF 62 p# subunit 62 CCR9 antagonist 62 Janus kinase 62 phosphate S1P 62 NPC 1C 62 XOMA 3AB biodefense 62 Epstein Barr Virus EBV 62 inhibit oxidative stress 62 ZFN modified 62 Sphingomab 62 XL# XL# XL# XL# 62 protein secreted 62 HuCAL R 62 Interferons 62 MOG #-# 62 dihydrochloride Tablets 62 include Altastaph TM 62 Recombinant Human 62 coronary vasodilation 62 Pruvel TM 62 prophylactic vaccines 62 #beta HSD1 62 Solazed TM 62 Macrophage 62 cytotoxic T lymphocyte 62 isotypes 62 protein kinase inhibitor 62 glucagon receptor 62 cyclin dependent kinase inhibitor 62 KRAS mutant 62 Viprovex R 62 CD# expressing 62 thyroid peroxidase 62 selectively inhibited 62 immunological responses 62 phosphoinositide 3 62 inhibit viral replication 62 Granulocyte Colony Stimulating Factor 62 oncolytic 62 K ras mutations 62 splice variants 62 Kinase Inhibitor 62 Nventa proprietary CoVal 62 MTP inhibitor 62 B Anflu R 62 RAF kinase VEGFR 62 IMPDH 62 TNF Tumor Necrosis Factor 62 factor receptor FGFR 62 5 HT2A inverse 62 CD#L 62 anti CD3 monoclonal 62 OR NATURE 62 Aurexis R 62 antibody mediated 62 NS5B polymerase 62 selective inverse agonist 62 cyclin dependent kinase 62 GnT 4a 62 upregulating 62 recombinant polyclonal antibodies 62 mitogen activated protein kinase 62 IGF1R 62 anti miRs antisense oligonucleotide 62 CDK5 62 CD# monoclonal antibody 62 humanized therapeutic 62 vaccine GRNVAC1 62 lymphoid organs 62 proapoptotic 62 VEGF receptors 62 PDGFR 62 By SABINA DANA 62 VEGF receptor 62 PEGylated anti 61 selective modulator 61 EphA2 61 TGF alpha 61 thymidylate synthase 61 adaptive immunity 61 ZFN TM 61 chemokine receptor 61 developing Bicifadine serotonin 61 Nedd4 61 Antigens 61 hepatoma 61 receptor CXCR4 61 delta gamma agonist 61 Chemokine Receptor 61 NEWS RELEASE THE COMPANY 61 polyglutamate 61 therapeutic monoclonal antibodies 61 Telik logo TELINTRA 61 ADAMTS# 61 PDE# 61 secretory phospholipase A2 61 essential thrombocythemia ET 61 antibody MT# 61 cytokines IL 61 Th2 cytokines 61 chronic eosinophilic leukemia 61 cell adhesion molecule 61 WEATHER OFFICE 61 leukocyte adhesion 61 XP# Transported Prodrug 61 anti CD# monoclonal 61 NEUGENE antisense 61 Raf kinase 61 PPAR peroxisome proliferator activated 61 OR ACHIEVEMENTS IMPLIED 61 underlying vasculopathy 61 CCX# 61 neutrophil recruitment 61 V#F mutation 61 histone deacetylase 61 highly selective inhibitor 61 #T# tumor 61 experimental autoimmune encephalomyelitis 61 vWF 61 extracellular signal 61 ligand TRAIL 61 Dendritic Cell 61 conventional siRNA molecules 61 polymerase inhibitors 61 TRANSDUR ® 61 SMaRT ™ 61 cytomegalovirus CMV 61 Akt signaling 61 small molecule thrombopoietin 61 MANAGEMENT 'S CURRENT BELIEFS 61 novel topoisomerase 61 histone deacetylation 61 Chinese hamster ovary 61 anti amnesic 61 inhibit replication 61 NKG2D 61 sulfonylhydrazine class 61 TKB# 61 targeted diseased tissues 61 HDAC enzymes 61 VEGFR2 inhibitor 61 calcitonin gene related 61 targets Galectin receptors 61 tumor antigen 61 SIX RO ROG 61 cathepsins 61 mediated apoptosis 61 partial agonist 61 PNP inhibitor 61 interferon γ 61 endogenous ligands 61 fucose 61 infectious diseases autoimmune diseases 61 neurite outgrowth 61 MKC# MT 61 interferon lambda 61 GVAX ® 61 NEUGENE 61 include Healive 61 Exelixis compounds 61 binds selectively 61 pancreatic islet beta 61 hyperphosphorylation 61 Locked Nucleic Acid LNA 61 lipoprotein Lp 61 apoptosis induced 61 cytotoxic T lymphocytes 61 PROfusion 61 CCR3 61 serine threonine kinase 61 Ovitrelle R Serostim 61 EVENT BRIEFS REFLECTS 61 Human cl 61 alkylated amino acid 61 hemagglutinin HA 61 Flt3 61 Overexpression 61 CONTROL WHICH MAY CAUSE 61 ocular formulation 61 Vidaza ® 61 kinase PI3K 61 varicella zoster virus VZV 61 UCP2 61 hypereosinophilic syndrome 61 mitogen activated protein kinases 61 IgG1 antibody 61 lintuzumab SGN 61 ErbB3 HER3 61 upregulate 61 AND ORAL STATEMENTS MADE 61 Bilive R combined 61 glycolipids 61 BCL2 61 deacetylation 61 MMAE 61 peripheral blood mononuclear 61 proprietary polysaccharide 61 Cytomegalovirus CMV 61 AND UNKNOWN COULD CAUSE 61 reversible inhibitor 61 ARE ONLY PREDICTIONS 61 RDEA# potent 61 methicillin susceptible 61 cyclic adenosine monophosphate cAMP 61 LAW IS NOT 61 MET RET 61 TLR7 agonist 61 targeting Inflammatory Bowel 61 NFκB 61 Oncogenic 61 constitutive activation 61 agonist compounds 61 HER2 HER2 61 auristatin E MMAE 61 regarding Aethlon Medical 61 HER pathway 61 drug monomethyl auristatin 61 carbohydrate polymer 61 CYP#A# isoenzyme 61 anticancer activity 61 Through Glycoscience R 61 WHICH ARE NOT PURELY 61 NEEDS WHICH MAY CAUSE 61 Polymorphisms 61 WHILE THE COMPANY 61 Ii protein 61 E#F# 61 PPARg 61 mitogenic 61 beta actin 61 Ep CAM 61 EGFR HER2 61 cytokine receptor 61 Hos2 61 non nucleoside inhibitor 61 PacketCable TM OpenCable TM 61 antisense inhibitors 61 protein tyrosine phosphatases 61 kinesin spindle protein 61 phosphatases 61 Xanafide 61 immune modulatory 61 EXCHANGE OR 61 pralatrexate injection folate analogue 61 Potassium Chloride Sodium Ascorbate 61 Lymphocytes 61 proprietary MSCRAMM ® 61 triggers apoptosis 61 M1 macrophages 61 4 PDE4 enzyme 61 M2e 60 THAT YOU GUYS 60 Vaxfectin 60 Medarex UltiMAb R 60 pDC 60 antiapoptotic 60 Panzem R 60 OR ACHIEVEMENTS TO BE 60 UNCERTAINTIES OR OTHER FACTORS 60 orally bioavailable mimics 60 p# MAP kinase 60 potent inducer 60 neuropathic pain metabolic diseases 60 IFN γ 60 prostaglandin E2 PGE2 60 induces antibodies 60 SIRT2 60 induces apoptosis 60 substantially excreted 60 Jhdm2a 60 Histone Deacetylase 60 5 HT6 receptor 60 CORT # 60 Payload TAP technology 60 oral JAK1 60 HCV protease 60 HER2 ErbB2 60 messenger ribonucleic acid 60 Integrins 60 FGFR3 60 peroxisome proliferator activated 60 LPA1 receptor 60 G Protein Coupled 60 extracellular domain 60 Ebola Marburg 60 antiproliferative activity 60 WILL DOW JONES ITS 60 ARE MADE AS 60 5 HT4 receptor 60 BY MARK FARINELLA 60 antioxidant enzymes 60 Cardium Therapeutics TM 60 humoral antibody 60 receptors PPARs 60 silicon carbide SiC gallium 60 TM Aganocide 60 Talabostat 60 p# mitogen activated 60 Notch receptors 60 NF kB activation 60 agonists antagonists 60 glial derived neurotrophic 60 SynCon ™ DNA 60 candidate alferminogene tadenovec 60 protein ADNP 60 clinically validated targets 60 constitutively expressed 60 antimetastatic activity 60 Cloud Headed Next 60 THR beta agonist 60 PEGylated Fab fragment 60 anthracycline induced 60 primary GeckoSavants 60 Multimeric 60 glutamic acid decarboxylase 60 alpha TNF 60 Thiovir 60 Immunotherapeutic 60 Vascular Endothelial Growth 60 receptor inhibitor 60 cyclooxygenase COX 60 fusion proteins 60 protease enzyme 60 directed radiotherapeutic antibody 60 Wafer polifeprosan 60 eNOS 60 * olmesartan medoxomil 60 glycosylation profile 60 product platforms AZX# 60 oncolytic viruses 60 THE COMPANY TO BE 60 include Healive TM 60 ABLYNX 60 CTLA 4 60 Monocytes 60 MDR1 60 drug conjugate 60 sarcoma melanoma 60 topoisomerase II inhibitor 60 Genius Glyder Stranded 60 receptor alpha 60 nuclease degradation 60 proteasome inhibitor 60 Thiarabine 60 AEG# 60 include PLX IBD 60 TRAIL receptor 60 naturally occurring neuroprotective 60 targetters 60 pRb 60 PROBLEMS WITH THE 60 palonosetron hydrochloride Injection Dacogen 60 eIF4E 60 mda 7 60 vesicular monoamine transporter 60 phosphatidylinositol 3 60 activity dependent neuroprotective 60 delay bone metastases 60 AND TO REOFFER 60 thrombin receptor 60 THE FUTURES CHARTS 60 microvascular endothelial cells 60 targeted antifolate 60 Rigel R# 60 STOP SHOPPING FOR 60 hyaluronidase enzyme 60 Symbioscience WISDOM PANEL 60 IMiDs ® 60 introduced NEUGENE 60 humanized anti 60 epithelial tumors 60 topical anti infectives 60 S. pyogenes 60 pan histone deacetylase 60 Treg cell 60 ON SUCH DOW JONES 60 CAUTIONARY STATEMENT UNDER 60 tumor xenograft models 60 pancreas esophagus 60 cyclin dependent kinases 60 BiTE ® 60 triphosphate 60 hemorrhagic fever viruses 60 colorectal bladder 60 regulates gene expression 60 tests miRview ™ 60 FULL IMPACT 60 Th# 60 ESPECIALLY WITH 60 oral isoform selective HDAC 60 Civacir TM Hepatitis C 60 TÎ ² 4 60 monocyte chemoattractant protein 60 carcinoids originate 60 Novel Oral 60 investigational humanized monoclonal antibody 60 NS5A 60 folate analogue metabolic 60 conserved antigens NP 60 gastric carcinogenesis 60 Note SHIPPING CHARGES 60 NS#/#A protease 60 β catenin 60 ADP receptor antagonist 60 Micromet proprietary BiTE 60 microsomal triglyceride transfer 60 flagellin 60 By XiaoBing #-#-# 60 tranquilizers diazepam 60 thrombin component 60 Upregulation 60 innate immune 60 ZFP transcription factors 60 WHEN YOU WERE DOWN 60 alpha2 60 TLR9 agonist 60 REPRESENTS THE EXPECTATIONS 60 thromboxane A2 60 morpholino 60 Anflu TM influenza 60 defensin mimetic antibiotic 60 OF SOURCES FROM WHICH 60 ACTCellerate 60 MAPKs 60 Clusterin 60 alkylating 60 mammaglobin 60 humanized monoclonal antibody 60 siRNA Delivery 60 TRIOLEX ™ 60 iNOS 60 surface proteins hemagglutinin 60 targeted radiotherapeutic 60 lymphotoxin 60 CompoZr 60 AFFILIATES AGENTS OR LICENSORS 60 Smac mimetics 60 hTERT 60 tumorigenicity 60 robust interlibrary loan 60 delipidation 60 chimeric monoclonal antibody 60 5 HT1A receptor 60 Fludara ® 60 NF kB pathway 60 NTDDS 60 reformulates existing FDA 60 ONCE AVAILABLE 60 BAL# [001] 60 evaluating picoplatin 60 LymphoStat B belimumab 60 ECONOMIC EVALUATIONS AND 60 OFFER FREE 60 receptor mediated endocytosis 60 Initiates Enrollment 60 TIME TO TEACH 60 TLR8 60 cytopathic 60 chemotherapy induced neutropenia 60 oncoprotein 60 excitatory neurotransmitter glutamate 60 monocytogenes Listeria vaccines 60 FGFR4 60 imatinib Gleevec ® 60 rxRNA 60 bevacizumab Avastin ® 60 TransVax tm 60 AdVac ® 60 humoral immune responses 60 Topoisomerase II 60 Signaling Pathway 60 THEREON 60 siRNA binds 60 immune modulator 60 COMPANY ASSUME ANY RESPONSIBILITY 60 xenograft models 60 ImmunoGen TAP technology 60 NS4A 60 Mucosal 60 CTLs 60 TGF b 60 2 inhibitor CYT# 59 TTR gene 59 human IgG1 monoclonal 59 Nicotine Conjugate Vaccine 59 FGFR2 59 glucocorticoid receptor 59 Tumor Necrosis Factor 59 immune modulators 59 Abeta# 59 DNA intercalator 59 oral dihydropyrimidine dehydrogenase DPD 59 XP# XP# 59 DOS# 59 selective antagonist 59 potent inhibition 59 serine protease 59 PINNACLEDIGEST.COM S PAST PERFORMANCE 59 sexually transmitted pathogens 59 activin receptor type 59 4SC AG ISIN DE# 59 THE STATEMENTS WHICH 59 stem cell pluripotency 59 adrenoceptor 59 LUCK Happy Birthday 59 BY JIM HAND 59 receptor partial agonist 59 BY PETER GOBIS 59 HTS assay 59 hemorrhage necrosis 59 potent recombinant 59 aT cell 59 humanized antibody 59 potent cytotoxic 59 PI3K/Akt 59 CagA 59 HIF1 alpha 59 HAS BEEN PREPARED BY 59 HIF PH 59 cytotoxin 59 RNA antagonist 59 generation nucleoside analog 59 DG# compounds targeting 59 Aganocide ® 59 HIF biology 59 Aztreonam formulated 59 mutated Ras 59 DNA methyltransferases 59 ANY WAY WITHOUT 59 potent anti angiogenic 59 SENOMYX 59 MVA BN ® 59 MUSICAL Kelsey Grammer 59 BioSante 2A/Furin technology 59 pro angiogenic 59 syngeneic 59 2 methoxyestradiol 59 Phosphorylation 59 Anticalins R 59 alpha#beta# 59 novel antiviral therapeutics 59 antisense compounds 59 Peroxisome Proliferator Activated Receptor 59 monoclonal 59 ® bortezomib 59 assay detects 59 Enterococcus faecalis vancomycin susceptible 59 4E BP1 59 Bilive TM combined 59 Nanobodies 59 acid phosphatase PAP 59 HER3 59 TLR7 59 DOES SEEKING ALPHA ASSUME 59 small molecule Hedgehog 59 IgG antibodies 59 receptor tyrosine kinase inhibitor 59 Adenoviral 59 peptibody 59 Aurora kinase 59 co stimulatory molecules 59 inhibitory activity 59 MATERIALS AS THEY BECOME 59 angiogenic responses 59 demonstrated antitumor activity 59 taxane derivative 59 Phospholipase A2 59 IS NOT LIMITED 59 rhIL 7 59 ACTION TAKEN BY 59 TRISCUIT crackers 59 HAAH 59 DHFR 59 Fibrin MB 59 non porcine pancreatic 59 IFN g 59 bispecific 59 constitutively activated 59 XL# XL# 59 adhesion molecule EpCAM expressing 59 5 FU leucovorin 59 vapreotide acetate 59 monoclonal antibodies mAbs 59 drugable targets 59 SinuNase TM 59 avidin 59 Plasmid DNA 59 human monoclonal antibody 59 MADE BASED UPON 59 novel orally administered 59 HER2 receptor 59 CD8 + 59 Initiates Phase II 59 intracellular protein 59 JAK2 Inhibitor 59 Angiotensin converting enzyme 59 siRNA sequences 59 TRIM5a 59 Ph + acute lymphoblastic 59 M1 muscarinic 59 CAN BE EXPECTED NEAR 59 T#I [002] 59 Onconase 59 YOU IN RELIANCE 59 Maxy G# 59 BY DAVID LINTON 59 reversible inhibitors 59 Crucell PER.C6 ® 59 cleavable linker 59 GRNOPC1 contains 59 regulated kinase 59 pharmacological chaperone 59 Hsp# chaperone system 59 CONTINUED ACCEPTANCE OF 59 CCR1 59 N acetylgalactosamine 6 59 novel antibody therapeutics 59 engineered proteases 59 BY REPRESENTATIVES OF 59 prostaglandin D2 59 FKBP# 59 XL# inhibits 59 autoantibody levels 59 telomerase therapeutic 59 opioid receptor antagonist 59 Receptors GPCRs 59 THE AUCTIONEER RESERVES 59 IgM antibodies 59 nicotinic acetylcholine receptor 59 tyrosine phosphorylation 59 S1P antibody 59 SHALL OR 59 BY LAUREN CARTER 59 multi kinase inhibitor 59 Nasdaq HALO biopharmaceutical 59 constitutively active 59 HIF 1α 59 inflammatory PDE 59 MT1 MMP 59 downregulates 59 chimeric antibody 59 BY ERIN MURPHY 59 orally dosed 59 IL 1β 59 non nucleoside 59 ErbB1 59 acetylcholine receptor 59 transgenic rats 59 transient receptor 59 Adenosine A2A 59 5alpha reductase 59 nucleotide analogs 59 POLYSHIELD ® POLYCLEAR ® 59 peptidomimetic 59 Perez Hipolito 59 AGENTS OR LICENSORS SHALL 59 TNF á 59 fusion enhancers 59 CONTROL IN PROCURING COMPILING 59 EZH2 59 THE MERGER CAREFULLY AND 59 OR ACHIEVEMENTS OF 59 malignant plasma 59 trastuzumab Herceptin R 59 decreased matrix metalloproteinase 59 ACTUAL RESULTS PERFORMANCE 59 phosphorylate 59 Bavituximab 59 Zemiva TM 59 uroguanylin 59 small molecule agonists 59 € žÂ ¢ ÃÆ'à 59 p glycoprotein 59 mesenchymal cell 59 investigational monoclonal antibody 59 toxic misfolded proteins 59 neuroprotective properties 59 世界 上 59 N methyl 59 integrase enzyme 59 ANGPTL4 59 CDK cyclin dependent 59 SHALL THE LIABILITY OF 59 Angiolix R 59 haematopoietic 59 prostanoid 59 INTERPRETING REPORTING OR DELIVERING 59 soluble TNF receptor 59 Akt activation 59 Anthrax Toxin 59 IN ANY TRANSCRIPT 59 ACC2 59 kinesin spindle protein KSP 59 ERK phosphorylation 59 potent inhibitors 59 ROUND ROBIN MIXED DOUBLES 59 WEB SITE OR 59 interferon alpha IFN 59 EGFr 59 inducible nitric oxide synthase 59 HuMax TAC 59 vaginal candidiasis 59 MET amplification 59 p#INK#a 59 multiple simultaneous immunological 59 Amgen Neulasta R 59 Ankara MVA 59 AND RELATED MATERIALS BECAUSE 59 Endothelial Cells 59 BOARD SAYS 59 REJECT ANY BID 59 potent antitumor activity 59 THAT ARE SUBJECT TO 59 influenza subtypes 59 HAS WRITTEN 59 IgG4 59 orthotopic model 59 Histone deacetylase 59 rusalatide acetate 59 RAF kinase 59 Posiphen 59 Xenon Headlamps ~ 59 TLR9 agonists 59 TNF α 59 WILL PARTICIPATE IN 59 VERANTWORTLICH 59 Sphingosine 1 59 AND ASSUMPTIONS AND 59 Etelos Cloud 59 human leukocyte antigens 59 Pain Neutralizer holds 59 TLR2 59 CD# CD# 59 OXIGON TM 59 By QianMian #-#-# 59 PEGylated 59 Division Schweinfurt Germany 59 cytotoxicity 59 elastase 59 recombinant PSMA vaccine 59 REPORTS FILED FROM 59 WAS PREPARED BY KINBAURI 59 metastatic neuroendocrine tumors